Andre T, Lonardi S, Wong KYM, et al. Combination of nivolumab (nivo) + ipilimumab (ip i) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 study. J Clin Oncol.